Article
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
2020-12-14
Abstract excerpt
Adoptive transfer of T cells expressing a transgenic T cell receptor (TCR) has the potential to revolutionize immunotherapy of infectious diseases and cancer. However, the generation of defined TCR-transgenic T cell medicinal products with predictable in vivo function still poses a major challenge and limits broader and more successful application of this ‘living drug’. Here, by studying 51 different TCRs, we show...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 28f6a18c-ae61-55d9-aa3a-757ea1f614cd
- DOI
- 10.1101/2020.12.14.20248169
